Defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in...

por Havas, Aaron P., Tula-Sanchez, Ana A., Steenhoek, Hailey M., Bhakta, Anvi, Wingfield, Taylor, Huntley, Matthew J., Nofal, Angela S., Ahmed, Tasmia, Jaime-Frias, Rosa, Smith, Catharine L.
Publicado 2023

A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma: Role of cyclin-dependent kinase inhibitors

por Tula-Sanchez, Ana A, Havas, Aaron P, Alonge, Peter J, Klein, Mary E, Doctor, Samantha R, Pinkston, William, Glinsmann-Gibson, Betty J, Rimsza, Lisa M, Smith, Catharine L
Publicado 2013